Deuterium-enriched pioglitazone
US9925175B2 · kind B2 · utility
7Cited by
17References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 1, 2016 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Apr 1, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.